Kalvista Pharmaceuticals Inc (KALV)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-04-11 | 2025-04-09 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
1,000
+0.5%
9.42USD 235,500 |
1,000 +0.5% | 9.42 | USD 100,000 | |
| 2025-03-10 | 2025-03-07 | S Sale |
CHIEF EXECUTIVE OFFICER Executive Director |
6,669
-2.3%
11.97USD 79,828 |
6,669 -2.3% | 11.97 | USD 79,828 | |
| 2025-02-25 | 2025-02-24 | S Sale |
CHIEF MEDICAL OFFICER Officer |
2,394
-2.3%
10.02USD 23,988 |
2,394 -2.3% | 10.02 | USD 23,988 | |
| 2025-02-25 | 2025-02-24 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
1,918
-2.0%
10.02USD 19,218 |
1,918 -2.0% | 10.02 | USD 19,218 | |
| 2025-02-19 | 2025-02-18 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
2,601
-2.7%
9.82USD 25,553 |
2,601 -2.7% | 9.82 | USD 25,553 | |
| 2025-02-19 | 2025-02-18 | S Sale |
CHIEF EXECUTIVE OFFICER Executive Director |
5,104
-1.8%
9.82USD 50,143 |
5,104 -1.8% | 9.82 | USD 50,143 | |
| 2025-02-19 | 2025-02-18 | S Sale |
CHIEF MEDICAL OFFICER Officer |
3,125
-3.0%
9.82USD 30,701 |
3,125 -3.0% | 9.82 | USD 30,701 | |
| 2025-02-14 | 2025-02-13 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
61,700
+1.2%
9.33USD 575,661 |
61,700 +1.2% | 9.33 | USD 575,661 | |
| 2025-02-14 | 2025-02-12 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
100,000
+2.0%
9.23USD 923,000 |
100,000 +2.0% | 9.23 | USD 923,000 | |
| 2025-02-11 | 2025-02-11 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
26,703
+0.5%
9.18USD 245,134 |
26,703 +0.5% | 9.18 | USD 245,134 | |
| 2025-02-11 | 2025-02-10 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
4,137
+0.1%
9.14USD 37,812 |
4,137 +0.1% | 9.14 | USD 37,812 | |
| 2025-02-11 | 2025-02-07 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
73,649
+1.5%
9.29USD 684,199 |
73,649 +1.5% | 9.29 | USD 684,199 | |
| 2025-02-03 | 2025-02-03 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
14,562
+0.3%
9.22USD 134,262 |
14,562 +0.3% | 9.22 | USD 134,262 | |
| 2025-02-03 | 2025-01-31 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
11,754
+0.2%
8.89USD 104,493 |
11,754 +0.2% | 8.89 | USD 104,493 | |
| 2025-02-03 | 2025-01-30 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
43,707
+0.9%
8.76USD 382,873 |
43,707 +0.9% | 8.76 | USD 382,873 | |
| 2024-12-09 | 2024-12-09 | S Sale |
CHIEF EXECUTIVE OFFICER Executive Director |
7,627
-2.7%
9.75USD 74,363 |
7,627 -2.7% | 9.75 | USD 74,363 | |
| 2024-11-27 | 2024-11-26 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
1,963
-2.1%
9.87USD 19,378 |
1,963 -2.1% | 9.87 | USD 19,378 | |
| 2024-11-27 | 2024-11-26 | S Sale |
CHIEF MEDICAL OFFICER Officer |
2,187
-2.2%
9.87USD 21,586 |
2,187 -2.2% | 9.87 | USD 21,586 | |
| 2024-11-19 | 2024-11-18 | S Sale |
CHIEF EXECUTIVE OFFICER Executive Director |
14,400
-5.1%
9.26USD 133,294 |
14,400 -5.1% | 9.26 | USD 133,294 | |
| 2024-11-19 | 2024-11-18 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
7,192
-7.4%
9.26USD 66,573 |
7,192 -7.4% | 9.26 | USD 66,573 | |
| 2024-11-19 | 2024-11-18 | S Sale |
CHIEF MEDICAL OFFICER Officer |
8,077
-7.9%
9.26USD 74,766 |
8,077 -7.9% | 9.26 | USD 74,766 | |
| 2024-09-10 | 2024-09-09 | S Sale |
CHIEF EXECUTIVE OFFICER Executive Director |
7,352
-2.8%
12.19USD 89,622 |
7,352 -2.8% | 12.19 | USD 89,622 | |
| 2024-08-26 | 2024-08-23 | S Sale |
CHIEF MEDICAL OFFICER Officer |
2,135
-2.5%
12.40USD 26,474 |
2,135 -2.5% | 12.40 | USD 26,474 | |
| 2024-08-26 | 2024-08-23 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
1,916
-2.2%
12.40USD 23,758 |
1,916 -2.2% | 12.40 | USD 23,758 | |
| 2024-08-21 | 2024-08-19 | S Sale |
CHIEF EXECUTIVE OFFICER Executive Director |
14,215
-5.5%
12.01USD 170,769 |
14,215 -5.5% | 12.01 | USD 170,769 | |
| 2024-08-21 | 2024-08-19 | S Sale |
CHIEF MEDICAL OFFICER Officer |
7,973
-9.0%
12.01USD 95,782 |
7,973 -9.0% | 12.01 | USD 95,782 | |
| 2024-08-21 | 2024-08-19 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
7,102
-7.8%
12.01USD 85,318 |
7,102 -7.8% | 12.01 | USD 85,318 | |
| 2024-06-10 | 2024-06-07 | S Sale |
CHIEF EXECUTIVE OFFICER Executive Director |
7,465
-3.2%
11.53USD 86,068 |
7,465 -3.2% | 11.53 | USD 86,068 | |
| 2024-05-21 | 2024-05-20 | S Sale |
CHIEF EXECUTIVE OFFICER Executive Director |
21,959
-9.2%
11.76USD 258,337 |
21,959 -9.2% | 11.76 | USD 258,337 | |
| 2024-05-21 | 2024-05-20 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
11,610
-12.7%
11.76USD 136,586 |
11,610 -12.7% | 11.76 | USD 136,586 | |
| 2024-05-21 | 2024-05-20 | S Sale |
CHIEF MEDICAL OFFICER Officer |
13,175
-15.8%
11.76USD 154,997 |
13,175 -15.8% | 11.76 | USD 154,997 | |
| 2024-05-21 | 2024-05-20 | S Sale |
CHIEF SCIENTIFIC OFFICER Officer |
8,088
-10.0%
11.76USD 95,151 |
8,088 -10.0% | 11.76 | USD 95,151 | |
| 2024-02-21 | 2024-02-20 | S Sale |
CHIEF MEDICAL OFFICER Officer |
14,295
-21.3%
14.12USD 201,774 |
14,295 -21.3% | 14.12 | USD 201,774 | |
| 2024-02-21 | 2024-02-20 | S Sale |
CFO, CBO Officer |
22,802
-10.9%
14.11USD 321,846 |
22,802 -10.9% | 14.11 | USD 321,846 | |
| 2024-02-21 | 2024-02-20 | PS Planned sale |
CHIEF SCIENTIFIC OFFICER Officer |
300
-0.5%
14.72USD 4,416 |
300 -0.5% | 14.72 | USD 4,416 | |
| 2024-02-21 | 2024-02-20 | PS Planned sale |
CHIEF SCIENTIFIC OFFICER Officer |
19,591
-23.9%
14.04USD 274,991 |
19,591 -23.9% | 14.04 | USD 274,991 | |
| 2024-02-21 | 2024-02-20 | S Sale |
CHIEF SCIENTIFIC OFFICER Officer |
8,397
-9.3%
14.11USD 118,522 |
8,397 -9.3% | 14.11 | USD 118,522 | |
| 2024-02-21 | 2024-02-20 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
12,053
-14.2%
14.11USD 170,124 |
12,053 -14.2% | 14.11 | USD 170,124 | |
| 2024-02-21 | 2024-02-20 | S Sale |
CEO Executive Director |
24,888
-10.5%
14.11USD 351,289 |
24,888 -10.5% | 14.11 | USD 351,289 | |
| 2024-02-16 | 2024-02-14 | S Sale |
CHIEF DEVELOPMENT OFFICER Officer |
39,886
-37.6%
15.01USD 598,661 |
39,886 -37.6% | 15.01 | USD 598,661 | |
| 2024-02-16 | 2024-02-14 | S Sale |
CFO, CBO Officer |
40,855
-20.4%
15.01USD 613,205 |
40,855 -20.4% | 15.01 | USD 613,205 | |
| 2024-02-16 | 2024-02-14 | S Sale |
CEO Executive Director |
58,356
-24.3%
15.01USD 875,883 |
58,356 -24.3% | 15.01 | USD 875,883 | |
| 2024-02-16 | 2024-02-14 | S Sale |
CHIEF SCIENTIFIC OFFICER Officer |
28,171
-28.2%
15.01USD 422,827 |
28,171 -28.2% | 15.01 | USD 422,827 | |
| 2024-02-08 | 2024-02-08 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
29,747
+0.6%
14.70USD 437,281 |
29,747 +0.6% | 14.70 | USD 437,281 | |
| 2024-02-08 | 2024-02-07 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
51,827
+1.1%
14.56USD 754,601 |
51,827 +1.1% | 14.56 | USD 754,601 | |
| 2024-02-08 | 2024-02-06 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
4,474
+0.1%
14.74USD 65,947 |
4,474 +0.1% | 14.74 | USD 65,947 | |
| 2024-02-05 | 2024-02-01 | PS Planned sale |
CEO Executive Director |
700
-0.6%
16.81USD 11,770 |
700 -0.6% | 16.81 | USD 11,770 | |
| 2024-02-05 | 2024-02-01 | PS Planned sale |
CEO Executive Director |
9,300
-7.3%
16.18USD 150,428 |
9,300 -7.3% | 16.18 | USD 150,428 | |
| 2024-02-01 | 2024-01-30 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
88,099
+1.9%
14.47USD 1,274,793 |
88,099 +1.9% | 14.47 | USD 1,274,793 | |
| 2024-01-29 | 2024-01-29 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
80,600
+1.8%
14.22USD 1,146,132 |
80,600 +1.8% | 14.22 | USD 1,146,132 | |
| 2024-01-29 | 2024-01-26 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
4,174
+0.1%
12.98USD 54,179 |
4,174 +0.1% | 12.98 | USD 54,179 | |
| 2024-01-29 | 2024-01-25 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
7,030
+0.2%
12.73USD 89,492 |
7,030 +0.2% | 12.73 | USD 89,492 | |
| 2024-01-24 | 2024-01-24 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
20,686
+0.5%
12.44USD 257,334 |
20,686 +0.5% | 12.44 | USD 257,334 | |
| 2024-01-24 | 2024-01-23 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
10,897
+0.2%
12.54USD 136,648 |
10,897 +0.2% | 12.54 | USD 136,648 | |
| 2024-01-24 | 2024-01-22 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
67,546
+1.5%
12.55USD 847,702 |
67,546 +1.5% | 12.55 | USD 847,702 | |
| 2024-01-19 | 2024-01-19 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
25,000
+0.6%
12.43USD 310,750 |
25,000 +0.6% | 12.43 | USD 310,750 | |
| 2024-01-19 | 2024-01-18 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
39,680
+0.9%
12.51USD 496,397 |
39,680 +0.9% | 12.51 | USD 496,397 | |
| 2024-01-19 | 2024-01-17 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
78,925
+1.8%
12.60USD 994,455 |
78,925 +1.8% | 12.60 | USD 994,455 | |
| 2024-01-16 | 2024-01-16 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
19,599
+0.5%
12.73USD 249,495 |
19,599 +0.5% | 12.73 | USD 249,495 | |
| 2024-01-16 | 2024-01-11 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
6,647
+0.2%
12.68USD 84,284 |
6,647 +0.2% | 12.68 | USD 84,284 | |
| 2024-01-12 | 2024-01-11 | PS Planned sale |
Chief Scientific Officer Officer |
22,679
-36.3%
13.03USD 295,514 |
22,679 -36.3% | 13.03 | USD 295,514 | |
| 2024-01-10 | 2024-01-10 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
47,700
+1.1%
12.67USD 604,359 |
47,700 +1.1% | 12.67 | USD 604,359 | |
| 2024-01-10 | 2024-01-09 | PS Planned sale |
Chief Scientific Officer Officer |
100
-0.2%
13.00USD 1,300 |
100 -0.2% | 13.00 | USD 1,300 | |
| 2024-01-10 | 2024-01-09 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
20,816
+0.5%
12.56USD 261,449 |
20,816 +0.5% | 12.56 | USD 261,449 | |
| 2024-01-10 | 2024-01-08 | PS Planned sale |
Chief Scientific Officer Officer |
17,221
-21.6%
13.01USD 224,000 |
17,221 -21.6% | 13.01 | USD 224,000 | |
| 2024-01-10 | 2024-01-08 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
69,184
+1.7%
12.44USD 860,649 |
69,184 +1.7% | 12.44 | USD 860,649 | |
| 2024-01-05 | 2024-01-04 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
41,764
+1.0%
12.11USD 505,762 |
41,764 +1.0% | 12.11 | USD 505,762 | |
| 2024-01-05 | 2024-01-03 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
17,605
+0.4%
12.20USD 214,781 |
17,605 +0.4% | 12.20 | USD 214,781 | |
| 2023-12-29 | 2023-12-29 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
6,013
+0.1%
12.49USD 75,102 |
6,013 +0.1% | 12.49 | USD 75,102 | |
| 2023-12-29 | 2023-12-28 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
471,490
+13.0%
12.50USD 5,893,625 |
471,490 +13.0% | 12.50 | USD 5,893,625 | |
| 2023-12-29 | 2023-12-27 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
41,514
+1.2%
11.97USD 496,923 |
41,514 +1.2% | 11.97 | USD 496,923 | |
| 2023-12-28 | 2023-12-27 | PS Planned sale |
CEO Executive Director |
30,000
-19.0%
12.02USD 360,453 |
30,000 -19.0% | 12.02 | USD 360,453 | |
| 2023-11-21 | 2023-11-20 | S Sale |
Chief Scientific Officer Officer |
4,958
-5.8%
8.23USD 40,801 |
4,958 -5.8% | 8.23 | USD 40,801 | |
| 2023-11-21 | 2023-11-20 | S Sale |
President, CFO, CBO & Sec'y Officer |
13,008
-10.4%
8.23USD 107,047 |
13,008 -10.4% | 8.23 | USD 107,047 | |
| 2023-11-21 | 2023-11-20 | S Sale |
CEO Executive Director |
14,807
-8.6%
8.23USD 121,851 |
14,807 -8.6% | 8.23 | USD 121,851 |